Trial Site Detail
Drug: |
BIIB021 (CNF2024) |
|||
|---|---|---|---|---|
Trial: |
Study of Oral CNF2024 in Advanced Solid Tumors |
|||
| Conditions: | Tumors, Lymphoma | |||
Trial Status: |
Completed |
|||
Virginia Piper Cancer Center10460 N. 92nd St. |
Principal Investigator: |
|
|---|---|
Contact: |
Contact: Biogen Idec, oncologyclinicaltrials@biogenidec.com Note: When contacting please refer to this study by ClinicalTrials.gov identifier NCT00345189 Note: This is a single point of contact for all CNF2024 Phase I sites. |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Virginia Piper Cancer Center Website: |
http://www.shc.org/Medical+Services/Cancer+Care/Cancer+Care |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.